首页 | 本学科首页   官方微博 | 高级检索  
检索        

药物洗脱支架治疗左主干病变的疗效评价
引用本文:吕树铮,李永斌.药物洗脱支架治疗左主干病变的疗效评价[J].心血管病学进展,2007,28(2):162-164.
作者姓名:吕树铮  李永斌
作者单位:首都医科大学附属北京安贞医院心内科,北京,100029
摘    要:冠脉搭桥术曾经被认为是左主干病变治疗的“金标准”,近年来经皮冠脉介入治疗也在该领域取得一些进展,一系列临床试验证实药物洗脱支架治疗左主干病变安全可行,但在左主干远端分叉病变还存在再狭窄率高的问题。就目前而言,对于有选择的左主干病变,药物洗脱支架是一种充满生机的治疗方法。

关 键 词:药物洗脱支架  左主干病变  冠脉搭桥术
文章编号:1004-3934(2007)02-0162-03
修稿时间:2007-02-05

Evaluating Effect of Treating Left Main Coronary Disease with Drug-eluting Stent
L Shu-zheng,LI Yong-bin.Evaluating Effect of Treating Left Main Coronary Disease with Drug-eluting Stent[J].Advances in Cardiovascular Diseases,2007,28(2):162-164.
Authors:L Shu-zheng  LI Yong-bin
Institution:Department of Cardiology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing 100029, China
Abstract:Coronary artery bypass grafting has long been considered the gold standard for left main coronary artery revascularization.However,percutaneous coronary intervention has made great progress in this area.Several clinical studies have proven it is safe and feasible to treat left main stenosis with drug-eluting stent(DES).The restenosis rate of distal bifurcation is still high in the DES era.Currently percutaneous revascularization is a viable therapeutic option in selected patients.
Keywords:drug-eluting stent  left main disease  coronary artery bypass grafting
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号